Patient P-02350
Synthetic patientMETA-24 · Day 133 · 65–74 · F · baseline S02Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
3%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S02
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability-7
- Nutritional resilience+7
- Inflammatory activity-3
- Toxicity+3
- Treatment adherence-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable78 min
improving · +5.6 vs previous 14 d
Sleep duration
Wearable6.8 h
improving · +0.3 vs previous 14 d
Energy level
Daily log7.7/10
stable · +0.3 vs previous 14 d
Steps
Wearable9,471
stable · +275 vs previous 14 d
GI burden
Companion0.9/100
improving · -9.0 vs previous 14 d
Adherence
Companion89.3 %
stable · +0.5 vs previous 14 d
Sleep quality
Wearable52.4/100
improving · +4.1 vs previous 14 d
Glucose, CGM daily mean
CGM120 mg/dL
improving · -6.7 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 100 from the failing basin, 19 from restoration.
Good elements to keep
- Protein (supports)perturbation · steering +11.9
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -6 next day
Main detractors to watch
- Rapid metabolizerhidden · steering -8
- Enterobacteriaceae elevatedhidden · steering -7.4
- Ultra-processed foodperturbation · steering -4.7
- Poor-sleep weekperturbation · steering -3
- Ultra-processed fooddetractor · GI +3.2 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6supporter · 95%
- Ultra-processed food+3.2detractor · 62%
- Dietary fat load+1.6no signal · 25%
- Alcohol+0.9no signal · 19%
- Histamine load-0.5no signal · 15%
- Insoluble fibre-0.4no signal · 15%
- Simple carbohydrates+0.2no signal · 15%
- Caffeine-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 71/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 7.4 h
- Steps
- 9,967
- Resting HR
- 66 bpm
Daily log: GI score 1, nutritional resilience 81, adherence 89.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.